Mobile

An Open-label, non-comparative, multi-centre study to assess the efficacy and safety of bicalutamide when used in combination with anastrozole for the treatment of gonadotropin-independent precocious ...

Mise à jour : Il y a 4 ans
Référence : EUCTR2004-000384-10

An Open-label, non-comparative, multi-centre study to assess the efficacy and safety of bicalutamide when used in combination with anastrozole for the treatment of gonadotropin-independent precocious puberty in boys with testotoxicosis

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

The primary objective of this study is to assess the efficacy of bicalutamide when used in combination with anastrozole in terms of a reduction in growth rate after 12 months treatment of precocious puberty in boys with testotoxicosis by assessment of change in growth rate after 12 months of treatment relative to the growth rate during the 6 months or more pre-study period.

Critère d'inclusion

  • testotoxicosis (familial male-limited gonadotropin-independent precocious puberty)

Liens